EBR Systems to Present at J.P. Morgan Conference as Cardiac Pacing Market Opportunity Swells

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has provided an announcement.

EBR Systems will present at the 44th Annual J.P. Morgan Healthcare Conference, where President and CEO John McCutcheon is set to brief investors on the company’s commercial progress, clinical programs and strategic priorities aimed at expanding adoption of its WiSE wireless cardiac pacing system. The company also disclosed that its estimated total addressable market has risen from US$3.6 billion to US$5.8 billion, reflecting the rapid expansion of the leadless pacemaker segment and higher expected average selling prices for the WiSE System, underscoring a significantly larger commercial opportunity for the business and its shareholders.

The most recent analyst rating on (AU:EBR) stock is a Hold with a A$0.87 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

Silicon Valley-based EBR Systems, Inc. is a medical device company focused on treating cardiac rhythm disease through its proprietary Wireless Stimulation Endocardially (WiSE) technology, the world’s only wireless, endocardial pacing system in clinical use for stimulating the heart’s left ventricle. Its initial product targets heart failure patients requiring Cardiac Resynchronisation Therapy by eliminating the need for coronary sinus leads, with future applications potentially extending to bradycardia and other non-cardiac indications.

Average Trading Volume: 572,936

Technical Sentiment Signal: Sell

Current Market Cap: A$443.2M

For a thorough assessment of EBR stock, go to TipRanks’ Stock Analysis page.